Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 5
Submit an article Journal homepage
268
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Successful management of chronic myeloid leukemia with a complication of anti-SRP antibody-associated myopathy

Kiyomi MoritaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;
,
Fumihiko NakamuraDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;
,
Kaori SakuishiDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
,
Tomotaka YamamotoDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
,
Jun ShimizuDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
,
Shoji TsujiDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
&
Mineo KurokawaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Correspondence[email protected]
 show all
Pages 1242-1245 | Received 30 Jun 2016, Accepted 02 Sep 2016, Published online: 10 Oct 2016

References

  • Ikeda K, Mita M, Ishibashi T, et al. Myositis caused by hydroxyurea in a patient with chronic myelogenous leukemia. Rinsho Ketsueki. 1998;39:676–679.
  • Nofal A, El-Din ES. Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption?. Int J Dermatol. 2012;51:535–541.
  • Miller T, Al-Lozi MT, Lopate G, et al. Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry. 2002;73:420–428.
  • Valiyil R, Casciola-Rosen L, Hong G, et al. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res (Hoboken). 2010;62:1328–1334.
  • Anderson LA, Pfeiffer RM, Landgren O, et al. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer. 2009;100:822–828.
  • Yang Z, Lin F, Qin B, et al. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol. 2015;42:282–291.
  • Chinoy H, Fertig N, Oddis CV, et al. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis. 2007;66:1345–1349.
  • le Coutre P, Reinke P, Neuhaus R, et al. BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients. Eur J Haematol. 2010;84:26–33.
  • Shrivastav A, Kumar V, Pal J. Dermatomyositis associated with acute myelocytic leukemia. Rheumatol Int. 2010;30:671–673.
  • Sweeney CL, Diers MD, Frandsen JL, et al. Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemia. J Pharmacol Exp Ther. 2002;300:1075–1084.
  • O'Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003;348:994–1004.
  • Penel N, Blay JY, Adenis A. Imatinib as a possible cause of severe rhabdomyolysis. N Engl J Med. 2008;358:2746–2747.
  • Malkan UY, Gunes G, Etgul S, et al. Management of de novo CML and imatinib-induced acute rhabdomyolysis with the second-generation TKI, dasatinib. Ann Pharmacother. 2015;49:740–742.
  • de Lavallade H, Punnialingam S, Milojkovic D, et al. Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis. Br J Haematol. 2008;141:745–747.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.